Efficacy of orally administered florfenicol and oxolinic acid for the treatment of vibriosis in cod (Gadus morhua)

Aquaculture

Volumn 235, Issue 1-4, 2004, Pages 27-35

  Samuelsen, Ole Bent ^a,b   Bergh, Øivind ^a  

^a INSTITUTE OF MARINE RESEARCH   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Antibacterial agents; Cod; Efficacy; Vibriosis

Indexed keywords

ANTIBIOTICS; BACTERIAL DISEASE; DISEASE CONTROL; GADOID;

GADUS; GADUS MORHUA; LISTONELLA; LISTONELLA ANGUILLARUM; VIBRIO;

EID: 2442474154     PISSN: 00448486     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0044-8486(03)00446-0     Document Type: Article

References (26)

1. Austin B., Rayment J., Alderman D.J. Control of furunculosis by oxolinic acid. Aquaculture. 31:1983;101-108
2. Bergh Ø. Også oppdrettstorsken kommer til å bli syk. Glette J., van der Meeren T., Olsen R.E., Skilbrei O. Havbruksrapporten 2002. Fisken og Havet. 2002;90-92 Institute of Marine Research, Bergen, Norway
3. Colwell R.R., Grimes D.J. Vibrio diseases of marine fish populations. Helgoländer Meeresuntersuchungen. 37:1984;265-287
4. Egidius E. Vibriosis: pathogenicity and pathology. A review. Aquaculture. 67:1987;15-28
5. Fukui H., Fujihara Y., Kano T. In-vitro and in-vivo antibacterial activities of florfenicol, a new fluorinated analogue of thiamphenicol, against fish pathogens. Fish Pathol. 22(4):1987;201-207
6. Grave K., Lillehaug A., Lunestad B.T., Horsberg T.E. Prudent use of antibacterial drugs in Norwegian aquaculture? Surveillance by the use of prescription data. Acta Vet. Scand. 40:1999;185-195
7. Horsberg T.E., Hoff K.A., Nordmo R. Pharmacokinetics of florfenicol and its metabolite florfenicol amine in Atlantic salmon. J. Aquat. Anim. Health. 8:1996;292-301
8. Inglis V., Richards R.H., Varma K.J., Sutherland I.H., Brokken E.S. Florfenicol in Atlantic salmon, Salmo salar L., parr: tolerance and assessment of efficacy against furunculosis. J. Fish Dis. 14:1991;343-351
9. Inglis V., Richards R.H. The in-vitro susceptibility of Aeromonas salmonicida and other fish pathogenic bacteria to 29 antimicrobial agents. J. Fish Dis. 14:1991;641-650
10. Martinsen B., Horsberg T.E. Comparative single-dose pharmacokinetics of four quinolones, oxolinic acid, flumequine, sarafloxacin and enrofloxacin in Atlantic salmon (Salmo salar) held in seawater at 10°C. Antimicrob. Agents Chemother. 39:1995;1059-1062
11. Nordmo R., Holth Riseth J.M., Varma K.J., Sutherland I.H., Brokken E.S. Evaluation of florfenicol in Atlantic salmon, Salmo salar L.: efficacy against furunculosis due to Aeromonas salmonicida and cold water vibriosis due to Vibrio salmonicida. J. Fish Dis. 21:1998;289-297
12. Poher I., Blanc G. Pharmacokinetics of a discontinuous absorption process of oxolinic acid in turbot, Scophthalmus maximus, after a single oral administration. Xenobiotica. 28:1998;1061-1073
13. Rodgers C.J., Austin B. Oxolinic acid for the control of enteric redmouth disease in rainbow trout. Vet. Rec. 112:1983;83
14. Rogstad A., Ellingsen O.F., Syvertsen C. Pharmacokinetics and bioavailability of flumequine and oxolinic acid after various routes of administration to Atlantic salmon in seawater. Aquaculture. 110:1993;207-220
15. Samuelsen O.B. Efficacy of bath-administered flumequine and oxolinic acid in the treatment of vibriosis in small atlantic halibut. J. Aquat. Anim. Health. 9:1997;127-131
16. Samuelsen O.B., Ervik A. A single-dose pharmacokinetic study of oxolinic acid and vetoquinol, an oxolinic acid ester, in Atlantic halibut (Hippoglossus hippoglossus) held in seawater at 9°C. J. Fish Dis. 22:1999;13-23
17. Samuelsen O.B., Lunestad B.T. Bath treatment, an alternative method for the administration of the quinolones flumequine and oxolinic acid to halibut Hippoglossus hippoglossus and in vitro antibacterial activity of the drugs against some Vibrio sp. Dis. Aquat. Org. 27:1996;13-18
18. Samuelsen O.B., Hjeltnes B., Glette J. Efficacy of orally administered Florfenicol in the treatment of furunculosis in Atlantic salmon. J. Aquat. Anim. Health. 10:1998;56-61
19. Samuelsen O.B., Hjeltnes B., Torkildsen L. Efficacy of orally administered oxolinic acid and vetoquinol, an oxolinic acid ester, in the treatment of furunculosis in Atlantic salmon Salmo salar held in seawater. Dis. Aquat. Org. 37:1999;53-59
20. Samuelsen O.B., Pursell L., Ervik A., Smith P. A single-dose pharmacokinetic study of oxolinic acid and vetoquinol, an oxolinic acid ester, in Atlantic salmon (Salmo salar) held in seawater and in vitro antibacterial activity against Aeromonas salmonicida. Aquaculture. 187:2000;213-224
21. Samuelsen O.B., Bergh Ø., Ervik A. A single-dose pharmacokinetic study of oxolinic acid and vetoquinol, an oxolinic acid ester, in cod (Gadus morhua) held in seawater at 8°C and in vitro antibacterial activity of oxolinic acid against Vibrio anguillarum strains isolated from diseased cod. J. Fish Dis. 26:2003;339-347
22. Shojaee AliAbadi F., Lees P. Antibiotic treatment for animals: effect on bacterial population and dosage regimen optimisation. Int. J. Antimicrob. Agents. 14:2000;307-313
23. Stamm J.M. In vitro resistance by fish pathogens to aquacultural antibacterials, including the quinolones difloxacin (A-56619) and sarafloxacin (A-56620). J. Aquat. Anim. Health. 1:1989;135-141
24. Torkildsen L., Samuelsen O.B., Lunestad B.T., Bergh Ø. Minimum inhibitory concentrations of chloramphenicol, florfenicol, trimethoprim/ sulfadiazine and flumequine in seawater of bacteria associated with scallops (Pecten maximus) larvae. Aquaculture. 185:2000;1-12
25. Torrissen O., Opstad I., Rødseth O. The veterinary approach to cod. Brown L. Aquaculture for Veterinarians. 1993;345-356 Pergamon
26. Washington J.A. II Susceptibility tests: agar dilution. Lennette E.H., Balows A., Hausler W.J. Jr., Shadomy H.J. Manual of Clinical Microbiology. 4th ed. 1985;967-971 American Society for Microbiology, Washington, DC